PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (SKIN + HAIR)
DRUG NAME: FINASTERIDE

• FDA Safety Data Sheet for oral finasteride may be found here.

• Piraccini BM. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022 [PubMed link]

• Keerti A. Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women. Cureus. 2023 [PubMed link]

• Gupta AK. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?. J Cosmet Dermatol. 2022 [PubMed link]

• Chen L. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis. Aesthetic Plast Surg. 2020 [PubMed link]

• Devjani S. Androgenetic Alopecia: Therapy Update. Drugs. 2023 [PubMed link]

• Khan MZU. Finasteride Topical Delivery Systems for Androgenetic Alopecia. Curr Drug Deliv. 2018 [PubMed link]

• Suchonwanit P. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature. J Dermatolog Treat. 2022 [PubMed link]

• Suchonwanit P. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2018 [PubMed link]

• Caserini M. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J Clin Pharmacol Ther. 2016 [PubMed link]

• Rossi A. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial. J Cosmet Dermatol. 2024 [PubMed link]